Concepedia

JR Keller

JK

27

Publications

3.1K

Citations

23

H-Index

1982

Active since

Affiliations

National Cancer Institute(Current)

Genesis Laboratories

Frederick National Laboratory for Cancer Research

National Institute of Allergy and Infectious Diseases

LabCorp (United States)

JR Keller is an author at National Cancer Institute specializing in immunology, medicine, and immunotherapy.

Top concepts

Publications per year

1982–1996

27

Publications

27

Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, P cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity

J N Ihle, JR Keller, L. Omar Henderson et al. · The Journal of Immunology · 1983 · 691 citations

, , +18

Procedures for the purification of interleukin 3 to homogeneity.

J N Ihle, JR Keller, L E Henderson et al. · The Journal of Immunology · 1982 · 418 citations

Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro

GK Sing, JR Keller, LR Ellingsworth et al. · Blood · 1988 · 223 citations · Full text

Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation?

Pierre Tiberghien, CW Reynolds, JR Keller et al. · Blood · 1994 · 216 citations

Phenotypic characteristics of cell lines requiring interleukin 3 for growth.

J N Ihle, JR Keller, Joel S. Greenberger et al. · The Journal of Immunology · 1982 · 158 citations · Full text

, , +14

Rows per page

1–5 of 27